Quiz: Post Market Surveillance, Vigilance and Incident Reporting

Quiz Summary

0 of 5 Questions completed

Questions:

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You must first complete the following:

Results

Quiz complete. Results are being recorded.

Results

0 of 5 Questions answered correctly

Your time:

You have reached 0 of 0 point(s), (0)

Question 1 of 5

1. Question

Post Market Surveillance involves the systematic collection and evaluation of data related to device performance after it has been released to the market.

True
Correct Incorrect Correct answer

False
Correct Incorrect Correct answer

Only for AI-based devices
Correct Incorrect Correct answer

Not required by MHRA
Correct Incorrect Correct answer

Correct / 1 Points

Incorrect / 1 Points
Question 2 of 5

2. Question

The MHRA expects manufacturers to maintain detailed records of surveillance activities including clinical data, user feedback, and software performance metrics.

This is not required by MHRA
Correct Incorrect Correct answer

The data must be reviewed regularly
Correct Incorrect Correct answer

The data must be stored for five years
Correct Incorrect Correct answer

The data must be reviewed annually
Correct Incorrect Correct answer

Correct / 1 Points

Incorrect / 1 Points
Question 3 of 5

3. Question

Incident reporting must be done in a timely manner and must be reviewed and documented within 30 days of discovery.

The clinical safety officer must be notified within 15 days
Correct Incorrect Correct answer

The clinical evaluation must be reviewed within 15 days
Correct Incorrect Correct answer

The clinical evaluation must be reviewed within 30 days
Correct Incorrect Correct answer

The clinical evaluation must be reviewed within 60 days
Correct Incorrect Correct answer

Correct / 1 Points

Incorrect / 1 Points
Question 4 of 5

4. Question

The clinical evaluation report must be updated regularly to reflect any new clinical data or clinical findings.

The clinical evaluation must be reviewed at least annually or whenever clinical data or clinical use changes significantly
Correct Incorrect Correct answer

The clinical evaluation must be reviewed only at the end of the device's lifecycle
Correct Incorrect Correct answer

The clinical evaluation must be reviewed only when clinical incidents occur
Correct Incorrect Correct answer

The clinical evaluation must be reviewed only when clinical trials are completed
Correct Incorrect Correct answer

Correct / 1 Points

Incorrect / 1 Points
Question 5 of 5

5. Question

ISO/IEC 42001:2023 provides guidance on implementing an AI management system that includes clinical surveillance and incident reporting processes.

The clinical safety officer must have access to clinical data and clinical evaluation reports
Correct Incorrect Correct answer

The clinical safety officer must have access to clinical data but not clinical evaluation reports
Correct Incorrect Correct answer

The clinical safety officer must have access to clinical data but not clinical incident data
Correct Incorrect Correct answer

The clinical safety officer must have access to clinical data but not clinical feedback
Correct Incorrect Correct answer

Correct / 1 Points

Incorrect / 1 Points

Quiz: Post Market Surveillance, Vigilance and Incident Reporting

Quiz Summary

Information

Results

Results

Categories

1. Question

2. Question

3. Question

4. Question

5. Question